Cited by 10Osteoarthritis Treatment and MechanismsPeriodontal Regeneration and TreatmentsMusculoskeletal pain and rehabilitation

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

The Potential of Intra-Articular Therapies in Managing Knee Osteoarthritis: A Systematic Review

Open access

Abstract

Background: Knee osteoarthritis (KOA) is a common degenerative and progressive joint disorder that negatively influences patients’ quality of life. Intra-articular therapies, such as hyaluronic acid (HA) and platelet-rich plasma (PRP), have garnered attention for their potential to manage osteoarthritis OA symptoms effectively. This systematic review aims to identify the effectiveness and safety of HA and PRP treatment modalities in treating KOA. Methods: A literature search was conducted across MEDLINE (PubMed), Web of Science Core Collection, and Science Direct Collection Elsevier. Twenty-three randomized controlled trials, cohort studies, and observational studies were included in the review. The selection criteria focused on studies published in English within the last 10 years, involving subjects with KOA treated with intra-articular injections of HA or PRP and reporting on pain, function, or overall treatment efficacy outcomes. Results: The analysis showed that both HA and PRP significantly improve functionality and reduce pain in KOA patients. High molecular weight HA consistently reduced pain and improved joint mobility in various studies. PRP had better long-term outcomes when combined with HA, leading to greater pain reduction and functional improvement. Both therapies had generally favorable safety profiles, with only minor adverse events reported. However, there were potential biases identified across the studies, such as selection, performance, detection, and reporting biases, which impacted the reliability of the results. Conclusions: Intra-articular treatments with HA and PRP show promise in managing knee osteoarthritis, with personalized treatment plans and further research needed to confirm these findings.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/clinpract14050157

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PRP appears to have limited benefit in Achilles tendinopathy and knee osteoarthritis, where trials reported no significant improvement over placebo.

    “PRP also appears to have limited benefit in certain conditions, such as Achilles tendinopathy and knee osteoarthritis, where trials have reported no significant improvement over placebo [109].”

    From Advancements in Regenerative Therapies for Orthopedics: A Comprehensive Review of Platelet-Rich Plasma, Mesenchymal Stem Cells, Peptide Therapies, and Biomimetic Applications (2025) · cites this paper as [109]

    The Results (§3.3; page unavailable) describe substantial improvements in pain and function with PRP for knee osteoarthritis, and the Discussion (§4.2; page unavailable) reports benefits over hyaluronic acid. This runs contrary to the claim of limited benefit for knee osteoarthritis, although the review does not establish the specific placebo comparison. The retrieved passages do not address Achilles tendinopathy. (LLM, conf=0.84)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured
  • PRP administered with hyaluronic acid or MSCs enhances regenerative capacity, particularly in knee osteoarthritis and cartilage repair.

    “Studies have explored PRP administered with hyaluronic acid (HA) or MSCs to enhance regenerative capacity, particularly in knee osteoarthritis and cartilage repair [109].”

    From Advancements in Regenerative Therapies for Orthopedics: A Comprehensive Review of Platelet-Rich Plasma, Mesenchymal Stem Cells, Peptide Therapies, and Biomimetic Applications (2025) · cites this paper as [109]

    Section 4.2 reports that PRP combined with HA improved pain and function in knee osteoarthritis, and separately discusses PRP’s potential to promote cartilage repair. It does not establish that the HA combination enhances cartilage regeneration. The Introduction mentions MSC treatment separately; although the References list a trial of MSCs with PRP, the cited passages do not report its findings or support an enhanced regenerative effect from that combination. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 80

  1. Safiri, 2020, Global, regional and national burden of osteoarthritis 1990–2017: A systematic analysis of the Global Burden of Disease Study 2017, Ann. Rheum. Dis., 79, 819, 10.1136/annrheumdis-2019-216515 · DOI
  2. Mallio, C.A., Bernetti, C., Agostini, F., Mangone, M., Paoloni, M., Santilli, G., Martina, F.M., Quattrocchi, C.C., Zobel, B.B., and Bernetti, A. (2023). Advanced MR Imaging for Knee Osteoarthritis: A Review on Local and Brain Effects. Diagnostics, 13. · DOI
  3. Safari, 2020, Digital Self-Management Interventions for People With Osteoarthritis: Systematic Review With Meta-Analysis, J. Med. Internet Res., 22, e15365, 10.2196/15365 · DOI
  4. Kumar, 2023, Quality of life and self-reported disability in patients with osteoarthritis: Cross-sectional descriptive study, J. Educ. Health Promot., 12, 81, 10.4103/jehp.jehp_1055_22 · DOI
  5. Hunter, 2019, Osteoarthritis, Lancet, 393, 1745.e59, 10.1016/S0140-6736(19)30417-9 · DOI
  6. Donell, 2019, Subchondral bone remodelling in osteoarthritis, EFORT Open Rev., 4, 221, 10.1302/2058-5241.4.180102 · DOI
  7. Kaspiris, A., Hadjimichael, A.C., Lianou, I., Iliopoulos, I.D., Ntourantonis, D., Melissaridou, D., Savvidou, O.D., Papadimitriou, E., and Chronopoulos, E. (2023). Subchondral Bone Cyst Development in Osteoarthritis: From Pathophysiology to Bone Microarchitecture Changes and Clinical Implementations. J. Clin. Med., 12. · DOI
  8. Thomas, 2014, Defining and mapping the person with osteoarthritis for population studies and public health, Rheumatology, 53, 338, 10.1093/rheumatology/ket346 · DOI
  9. Blanco, 2020, Prevalence of symptomatic osteo-arthritis in Spain: EPISER2016 study, Reumatol. Clin., 17, 461, 10.1016/j.reuma.2020.01.008 · DOI
  10. Swain, 2020, Trends in incidence and prevalence of osteoarthritis in the United Kingdom: Findings from the clinical practice research datalink (CPRD), Osteoarthr. Cartil., 28, 792, 10.1016/j.joca.2020.03.004 · DOI
  11. Yu, 2017, Population trends in the incidence and initial management of osteoarthritis: Age-period-cohort analysis of the Clinical Practice Research Datalink, 1992–2013, Rheumatology, 56, 1902, 10.1093/rheumatology/kex270 · DOI
  12. Vina, 2018, Epidemiology of osteoarthritis: Literature update, Curr. Opin. Rheumatol., 30, 160, 10.1097/BOR.0000000000000479 · DOI
  13. Jordan, 2007, Prevalence of knee symptoms and radiographic and symptomatic knee osteoarthritis in African Americans and Caucasians: The johnston county osteoarthritis project, J. Rheumatol., 34, 172
  14. Li, D., Li, S., Chen, Q., and Xie, X. (2020). The prevalence of symptomatic knee osteoarthritis in relation to age, sex, area, region, and body mass index in China: A systematic review and meta-analysis. Front. Med., 7. · DOI
  15. Hong, J.W., Noh, J.H., and Kim, D.J. (2020). The prevalence of and demographic factors associated with radiographic knee osteoarthritis in Korean adults aged >/= 50 years: The 2010–2013 Korea National Health and Nutrition Examination Survey. PLoS ONE, 15. · DOI
  16. Driban, J.B., Bannuru, R.R., Eaton, C.B., Spector, T.D., Hart, D.J., McAlindon, T.E., Lu, B., Lo, G.H., and Arden, N.K. (2020). The incidence and characteristics of accelerated knee osteoarthritis among women: The Chingford cohort. BMC Musculoskelet. Disord., 21. · DOI
  17. Losina, 2013, Lifetime risk and age at diagnosis of symptomatic knee osteoarthritis in the US, Arthritis Care Res., 65, 703, 10.1002/acr.21898 · DOI
  18. Allen, 2022, Epidemiology of osteoarthritis, Osteoarthritis and cartilage., 30, 184, 10.1016/j.joca.2021.04.020 · DOI
  19. Kim, 2014, Prevalence of radiographic and symptomatic hip osteoarthritis in an urban United States community: The Framingham osteoarthritis study, Arthritis Rheumatol., 66, 3013, 10.1002/art.38795 · DOI
  20. Iidaka, 2020, Incidence rate and risk factors for radiographic hip osteoarthritis in Japanese men and women: A 10-year follow-up of the ROAD study, Osteoarthr. Cartil., 28, 182, 10.1016/j.joca.2019.09.006 · DOI
  21. Kloprogge, 2023, Prevalence of radiographic ankle osteoarthritis in different subgroups of patients referred for ankle radiography, Semin. Arthritis Rheum., 58, 152138, 10.1016/j.semarthrit.2022.152138 · DOI
  22. Murray, C., Marshall, M., Rathod, T., Bowen, C.J., Menz, H.B., and Roddy, E. (2018). Population prevalence and distribution of ankle pain and symptomatic radiographic ankle osteoarthritis in community dwelling older adults: A systematic review and cross-sectional study. PLoS ONE, 13. · DOI
  23. (2024, April 04). Global, Regional, and National Burden of Osteoarthritis, 1990–2020 and Projections to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021 GBD 2021 Osteoarthritis Collaborators*. Available online: https://www.thelancet.com/journals/lanrhe/article/piis2665-9913(23)00163-7/fulltext.
  24. Michael, 2010, The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee, Dtsch. Arztebl. Int., 107, 152
  25. Chang, 2018, Systemic and local adipose tissue in knee osteoarthritis, Osteoarthr. Cartil., 26, 864, 10.1016/j.joca.2018.03.004 · DOI
  26. Du, 2023, Research Progress on the Pathogenesis of Knee Osteoarthritis, Orthop. Surg., 15, 2213, 10.1111/os.13809 · DOI
  27. Edd, 2015, The role of inflammation in the initiation of osteoarthritis after meniscal damage, J. Biomech., 48, 1420, 10.1016/j.jbiomech.2015.02.035 · DOI
  28. Sulzbacher, 2013, Osteoarthritis: Histology and pathogenesis, Wien. Med. Wochenschr., 163, 212, 10.1007/s10354-012-0168-y · DOI
  29. Kubassova, 2019, Osteoarthritis phenotypes and novel therapeutic targets, Biochem. Pharmacol., 165, 41, 10.1016/j.bcp.2019.02.037 · DOI
  30. Zou, M., and Shao, Z. (2024). Proteome-Wide Mendelian Randomization and Colocalization Analysis Identify Therapeutic Targets for Knee and Hip Osteoarthritis. Biomolecules, 14. · DOI
  31. Kim, 2022, Dysregulated circular RNAs and their pathological implications in knee osteoarthritis: Potential novel therapeutic targets and diagnostic biomarkers, All Life, 15, 23, 10.1080/26895293.2021.2020172 · DOI
  32. Muschter, 2020, Recent advances in the treatment of osteoarthritis, F1000Research, 9, 325, 10.12688/f1000research.22115.1 · DOI
  33. Kolasinski, 2020, 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee, Arthritis Rheumatol., 72, 220, 10.1002/art.41142 · DOI
  34. Bannuru, 2019, OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis, Osteoarthr. Cartil., 27, 1578, 10.1016/j.joca.2019.06.011 · DOI
  35. Richard, 2022, Pharmaceutical treatment of osteoarthritis, Osteoarthr. Cartil., 31, 458, 10.1016/j.joca.2022.11.005 · DOI
  36. Gilat, 2021, Hyaluronic acid and platelet-rich plasma for the management of knee osteoarthritis, Int. Orthop., 45, 345, 10.1007/s00264-020-04801-9 · DOI
  37. Bhandari, 2017, Intra-articular hyaluronic acid in the treatment of knee osteoarthritis: A Canadian evidence-based perspective, Ther. Adv. Musculoskelet. Dis., 9, 231, 10.1177/1759720X17729641 · DOI
  38. Wu, 2020, Platelet-rich plasma versus hyaluronic acid in knee osteoarthritis: A meta-analysis with the consistent ratio of injection, J. Orthop. Surg., 28, 2309499019887660, 10.1177/2309499019887660 · DOI
  39. Lin, 2019, Intra-articular injection of platelet-rich plasma is superior to hyaluronic acid or saline solution in the treatment of mild to moderate knee osteoarthritis: A randomized, double-blind, triple-parallel, placebo-controlled clinical trial, Arthrosc. J. Arthrosc. Relat. Surg., 35, 106, 10.1016/j.arthro.2018.06.035 · DOI
  40. Blanco, 2020, Phase II multicenter randomized controlled clinical trial on the efficacy of intra-articular injection of autologous bone marrow mesenchymal stem cells with platelet rich plasma for the treatment of knee osteoarthritis, J. Transl. Med., 18, 356, 10.1186/s12967-020-02530-6 · DOI · Paper page
  41. Giorgino, R., Albano, D., Fusco, S., Peretti, G.M., Mangiavini, L., and Messina, C. (2023). Knee Osteoarthritis: Epidemiology, Pathogenesis, and Mesenchymal Stem Cells: What Else Is New? An Update. Int. J. Mol. Sci., 24. · DOI
  42. Sathiyanarayanan, 2017, Usefulness of WOMAC index as a screening tool for knee osteoarthritis among patients attending a rural health care center in Tamil Nadu, Int. J. Community Med. Public Health, 4, 4290, 10.18203/2394-6040.ijcmph20174846 · DOI
  43. Hegedus, 2010, Clinimetrics corner: The many faces of selection bias, J. Man. Manip. Ther., 18, 69, 10.1179/106698110X12640740712699 · DOI
  44. Altman, 2001, Assessing the quality of controlled clinical trials, BMJ, 323, 42, 10.1136/bmj.323.7303.42 · DOI · Paper page
  45. Babu, 2023, Clinical and radiological efficacy of single-dose intra-articular high-molecular-weight hyaluronic acid in knee osteoarthritis, J. Fam. Med. Prim. Care, 12, 1692, 10.4103/jfmpc.jfmpc_486_23 · DOI
  46. Raeissadat, S.A., Ghazi Hosseini, P., Bahrami, M.H., Salman Roghani, R., Fathi, M., Gharooee Ahangar, A., and Darvish, M. (2021). The comparison effects of intra-articular injection of Platelet Rich Plasma (PRP), Plasma Rich in Growth Factor (PRGF), Hyaluronic Acid (HA), and ozone in knee osteoarthritis; a one year randomized clinical trial. BMC Musculoskelet. Disord., 22. · DOI · Paper page
  47. Blicharski, T., Łukasik, P., Plebanski, R., Żęgota, Z., Szuścik, M., Moster, E., Pavelka, K., Jeon, S., and Park, S.L. (2023). Efficacy and Safety of Intra-Articular Cross-Linked Sodium Hyaluronate for the Treatment of Knee Osteoarthritis: A Prospective, Active-Controlled, Randomized, Parallel-Group, Double-Blind, Multicenter Study. J. Clin. Med., 12. · DOI
  48. Calvet, J., Khorsandi, D., Tío, L., and Monfort, J. (2022). Evaluation of a single-shot of a high-density viscoelastic solution of hyaluronic acid in patients with symptomatic primary knee osteoarthritis: The no-dolor study. BMC Musculoskelet. Disord., 23. · DOI
  49. Acharya, 2022, Improvement in condition specific and generic quality of life outcomes in patients with knee osteoarthritis following single intraarticular viscosupplementation injection, J. Clin. Orthop. Trauma, 27, 101828, 10.1016/j.jcot.2022.101828 · DOI
  50. Hill, W.S., Dohnalek, M.H., Ha, Y., Kim, S.J., Jung, J.C., and Kang, S.B. (2023). A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of a Krill Oil, Astaxanthin, and Oral Hyaluronic Acid Complex on Joint Health in People with Mild Osteoarthritis. Nutrients, 15. · DOI
  51. Nouri, F., Babaee, M., Peydayesh, P., Esmaily, H., and Raeissadat, S.A. (2020). Comparison between the efects of ultrasound guided intra-articular injections of platelet-rich plasma (PRP), high molecular weight hyaluronic acid, and their combination in hip osteoarthritis: A randomized clinical trial. BMC Musculoskelet. Disord., 23. · DOI
  52. Szwedowski, D., Mobasheri, A., Moniuszko, A., Zabrzyński, J., and Jeka, S. (2022). Intra-Articular Injection of Platelet-Rich Plasma Is More Effective than Hyaluronic Acid or Steroid Injection in the Treatment of Mild to Moderate Knee Osteoarthritis: A Prospective, Randomized, Triple-Parallel Clinical Trial. Biomedicines, 10. · DOI
  53. Sconza, 2023, Safety and Efficacy of Hybrid Cooperative Complexes of Sodium Hyaluronate and Sodium Chondroitin for the Treatment of Patients with Symptomatic Knee Osteoarthritis, Rheumatol. Ther., 11, 381, 10.1007/s40744-024-00643-8 · DOI
  54. Perruchet, 2023, The Association between Radiographic Features and the Duration of Effectiveness of a Single Injection of Extended-Release Hyaluronic Acid (HANOX-M-XL) in Patients with Knee Osteoarthritis: Preliminary Results of a Prospective Trial, Cartilage, 14, 136, 10.1177/19476035221109230 · DOI
  55. Galluccio, 2022, The booster effect of a single quarterly dose of hyaluronic acid in knee osteoarthritis: Five-year results of a registry-based study, Cureus, 14, e31592
  56. Tschopp, 2023, A Randomized Trial of Intra-articular Injection Therapy for Knee Osteoarthritis, Investig. Radiol., 58, 355, 10.1097/RLI.0000000000000942 · DOI
  57. Kurt, 2024, Effectiveness of gonarthrosis treatment via in-tra-articular injections of linear vs. cross-linked hyaluronic acids, Jt. Dis. Relat. Surg., 35, 138, 10.52312/jdrs.2023.1403 · DOI
  58. Colombini, A., Doro, G., Ragni, E., Forte, L., de Girolamo, L., and Zerbinati, F. (2023). Treatment with CR500® improves algofunctional scores in patients with knee osteoarthritis: A post-market confirmatory interventional, single arm clinical investigation. BMC Musculoskelet. Disord., 24. · DOI
  59. Ciapini, 2023, Is the Combination of Platelet-Rich Plasma and Hyaluronic Acid the Best Injective Treatment for Grade II-III Knee Osteoarthritis? A Prospective Study, Adv. Orthop., 2023, 1868943, 10.1155/2023/1868943 · DOI
  60. Tammachote, 2016, Intra-Articular, Single-Shot Hylan G-F 20 Hyaluronic Acid Injection Compared with Corticosteroid in Knee Osteoarthritis: A Double-Blind, Randomized Controlled Trial, J. Bone Jt. Surg., 98, 885, 10.2106/JBJS.15.00544 · DOI
  61. Hermans, J., Bierma-Zeinstra, S.M.A., Bos, P.K., Niesten, D.D., Verhaar, J.A.N., and Reijman, M. (2019). The effectiveness of high molecular weight hyaluronic acid for knee osteoarthritis in patients in the working age: A randomised controlled trial. BMC Musculoskelet. Disord., 20. · DOI
  62. Bashaireh, 2015, Efficacy and safety of cross-linked hyaluronic acid single injection on osteoarthritis of the knee: A post-marketing phase IV study, Drug Des. Dev. Ther., 9, 2063, 10.2147/DDDT.S81524 · DOI
  63. Altay, 2016, Will a single periarticular lidocaine-corticosteroid injection improve the clinical efficacy of intraarticular hyaluronic acid treatment of symptomatic knee osteoarthritis?, Knee Surg. Sports Traumatol. Arthrosc. Off. J. ESSKA, 24, 3653, 10.1007/s00167-014-3398-2 · DOI
  64. Ricci, 2017, Clinical comparison of oral administration and viscosupplementation of hyaluronic acid (HA) in early knee osteoarthritis, Musculoskelet. Surg., 101, 45, 10.1007/s12306-016-0428-x · DOI
  65. Tang, 2015, Intra-articular intervention by hyaluronic acid for knee osteoarthritis can modify locomotor pattern of muscle activity, Clin. Neurol. Neurosurg., 129, S16, 10.1016/S0303-8467(15)30006-8 · DOI
  66. Lisi, 2018, Treatment of knee osteoarthritis: Platelet-derived growth factors vs. hyaluronic acid. A randomized controlled trial, Clin. Rehabil., 32, 330, 10.1177/0269215517724193 · DOI
  67. Papio, 2019, Platelet-Rich Plasma Versus Hyaluronic Acid Injections for the Treatment of Knee Osteoarthritis: Results at 5 Years of a Double-Blind, Randomized Controlled Trial, Am. J. Sports Med., 47, 347, 10.1177/0363546518814532 · DOI
  68. Balusani, 2024, Navigating the Therapeutic Landscape: A Comprehensive Review of Platelet-Rich Plasma and Bone Marrow Aspirate Concentrate in Knee Osteoarthritis, Cureus, 16, e54747
  69. Shang, 2023, A systematic review, umbrella review, and quality assessment on clinical translation of stem cell therapy for knee osteoarthritis: Are we there yet?, Stem Cell Res. Ther., 14, 91, 10.1186/s13287-023-03332-5 · DOI
  70. Khalid, 2023, Comparative effectiveness of intra-articular therapies in knee osteoarthritis: A meta-analysis comparing platelet-rich plasma (PRP) with other treatment modalities, Ann. Med. Surg., 86, 361, 10.1097/MS9.0000000000001615 · DOI
  71. Qiao, X., Yan, L., Feng, Y., Li, X., Zhang, K., Lv, Z., Xu, C., Zhao, S., Liu, F., and Yang, X. (2023). Efficacy and safety of corticosteroids, hyaluronic acid, and PRP and combination therapy for knee osteoarthritis: A systematic review and network meta-analysis. BMC Musculoskelet. Disord., 24. · DOI
  72. Lana, 2016, Randomized controlled trial comparing hyaluronic acid, platelet-rich plasma and the combination of both in the treatment of mild and moderate osteoarthritis of the knee, J. Stem. Cells Regen. Med., 12, 69, 10.46582/jsrm.1202011 · DOI
  73. Zhao, J., Huang, H., Liang, G., Zeng, L.-F., Yang, W., and Liu, J. (2020). Effects and safety of the combination of platelet-rich plasma (PRP) and hyaluronic acid (HA) in the treatment of knee osteoarthritis: A systematic review and meta-analysis. BMC Musculoskelet. Disord., 21. · DOI
  74. Nicholls, 2019, The impact of excluding patients with end-stage knee disease in in-tra-articular hyaluronic acid trials: A systematic review and meta-analysis, Adv Ther., 36, 147, 10.1007/s12325-018-0847-1 · DOI
  75. Huang, H.Y., Hsu, C.W., Lin, G.C., Lin, H.S., Chou, Y.J., Liou, I.H., and Sun, S.F. (2022). Comparing efficacy of a single intraarticular injection of platelet-rich plasma (PRP) combined with different hyaluronans for knee osteoarthritis: A randomized-controlled clinical trial. BMC Musculoskelet Disord., 23. · DOI
  76. Chen, 2016, Clinical effectiveness in severe knee osteoarthritis after intra-articular plate-let-rich plasma therapy in association with hyaluronic acid injection: Three case reports, Clin. Interv. Aging, 11, 1213, 10.2147/CIA.S114795 · DOI
  77. Amirsaadat, S., Amirazad, H., Hashemihesar, R., and Zarghami, N. (2023). An update on the effect of intra-articular intervention strategies using nanomaterials in osteoarthritis: Possible clinical application. Front. Bioeng. Biotechnol., 11. · DOI
  78. Waters, 2023, Analysis of the Evidence Underpinning the American Academy of Orthopedic Surgeons Knee Osteoarthritis Clinical Practice Guidelines, Sports Health, 15, 11, 10.1177/19417381221112674 · DOI
  79. Osteoarthritis (L King, Section Editor) (2023, July 01). Intra-Articular Therapies for Knee Osteoarthritis: Current Update. Available online: https://link.springer.com/article/10.1007/s40674-023-00207-x#citeas. · DOI
  80. Cui, 2020, Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies, EClinicalMedicine, 29–30, 100587, 10.1016/j.eclinm.2020.100587 · DOI

Cited by

Sorted by citations

Metadata

Authors
Pojala, C. V., Toma, S., Costache, C., Peter, T., Pojala, C. E., Roman, N. A., & Dima, L.
Affiliations
  • University of Medicine and Pharmacy of Craiova (RO)
  • Transilvania University of Brașov (RO)
Corresponding author
Roman, Nadinne Alexandra
Venue
Clinics and Practice
Publisher
MDPI AG
Published
2024-09-25
Volume
14
Issue
5
Pages
1970-1996
ISSN
  • 2039-7275 (ISSN-L)
  • 2039-7283
OpenAlex
W4402922478
Cited by
10
References
5
Citations by year
2026: 4 · 2025: 6
FWCI
0.74
Type
journal article
Language
en
Open access
Locations
  • Clinics and Practice (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
  • Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
  • Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
Keywords
knee osteoarthritis, intra-articular therapy, hyaluronic acid, platelet-rich plasma, analgesia, joint function, treatment efficacy, treatment safety, high molecular weight hyaluronic acid, combination therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review